Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000557981 | SCV000650936 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001725189 | SCV001960510 | benign | not provided | 2021-02-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002431678 | SCV002729368 | likely benign | Cardiovascular phenotype | 2019-03-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV001725189 | SCV004565322 | likely benign | not provided | 2023-10-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001725189 | SCV005093561 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | FLNC: BP4, BS1, BS2 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001701044 | SCV005204799 | likely benign | not specified | 2024-06-17 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001725189 | SCV005221594 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV001701044 | SCV001918481 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001725189 | SCV001974014 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003925674 | SCV004739266 | likely benign | FLNC-related disorder | 2019-05-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |